The US regulator has said that compounders can continue to trade in tirzepatide products while it undertakes a review to ...

Analysts say the number of private prescriptions for fat busting jabs like Ozempic in the UK are predicted to soar to over ...

Just 800 of the 13,500 patients eligible to start receiving Wegovy, which can help obese people lose 15% of their body weight ...

The former immigration minister, who lost four stone in 12 months, said the drug had aided him at the start of his bid to ...

There is no perfect definition of healthy or unhealthy food. There is no perfect system of regulation. But I believe that ...

Weight-loss drug Wegovy will go on sale in Korea on Tuesday, with the much-anticipated injectable drug available for order ...

New drugs from public and private companies are expected to saturate the obesity drug market. Novo Nordisk and Eli Lilly are currently dominating the weight loss drug market, but biopharmaceutical ...

When you think of brain stimulating medtech, startups building wearables as therapeutics probably aren't the first thing that ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

This is an audio transcript of the Life and Art from FT Weekend podcast episode: ‘Fashion loves Ozempic. Should we talk about it?’ ...

Thousands of people with severe obesity are being denied access to effective treatment because the NHS rollout of the weight ...